首页> 中文期刊>中外医学研究 >复方丹参注射液联合硫酸镁治疗对子痫前期患者血压与尿蛋白含量的影响

复方丹参注射液联合硫酸镁治疗对子痫前期患者血压与尿蛋白含量的影响

     

摘要

目的:探讨复方丹参注射液联合硫酸镁治疗子痫前期的临床疗效。方法:选取笔者所在医院收治的子痫前期孕妇216例作为研究对象,对照组108患者给予硫酸镁降压治疗,试验组108例患者在此基础上加用复方丹参注射液联合治疗。对比两组患者血压、尿蛋白含量变化及治疗效果。结果:试验组总有效率(95.4%)明显高于对照组,差异有统计学意义(χ²=17.755,P<0.05);治疗后试验组平均动脉压(90.5±24.2)mm Hg,24 h尿蛋白含量(323.1±31.4)mg,明显低于对照组,差异有统计学意义(P<0.05)。结论:复方丹参注射液联合硫酸镁治疗子痫前期,降血压、降低尿蛋白效果理想,不良反应较少,值得临床推广应用。%Objective:To investigate the clinical efficacy of Danshen injection combined with magnesium sulfate therapy in patients with preeclampsia. Method:216 pregnant women with preeclampsia in our hospital were as the research object,108 patients in the control group were given magnesium sulfate antihypertensive treatment,the other 108 patients in the treatment group were given Danshen injection based on the use of magnesium sulfate.Blood pressure, urine protein in two groups of patients and the treatment effect were compared.Result:The total efficiency of the treatment group was 95.4%,significantly higher than that in the control group(χ²=17.755,P<0.05).After treatment,mean arterial pressure was (90.5±24.2)mm Hg in the treatment group,24 h urine protein levels was(323.1±31.4)mg,significantly lower than that in the control group(P<0.05).Conclusion:Danshen injection combined with magnesium sulfate for treatment of preeclampsia,can lower blood pressure,reduce urinary protein,has fewer side effects,is worthy of clinical application.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号